M. Zacarías-Fluck

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding

J. Arribas, L. Larsson, V. Serra, 2022, Cancer research communications.

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies

R. Schlegel, J. Tabernero, P. Nuciforo, 2015, PloS one.

Effect of cellular senescence on the growth of HER2-positive breast cancers.

J. Arribas, J. Villanueva, I. Rubio, 2015, Journal of the National Cancer Institute.

Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.

J. Baselga, P. Nuciforo, A. Pandiella, 2014, Journal of the National Cancer Institute.

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts

S. Cosimo, J. Arribas, A. Prat, 2016, Oncotarget.

The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets

G. Evan, L. Brown-Swigart, D. Virshup, 2021, Life Science Alliance.

Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy

M. Guenther, P. Rahl, J. Whitfield, 2019, Science Translational Medicine.

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting

O. Scharovsky, V. Rozados, M. Rico, 2014, Journal of Biomedical Science.